fda-consultant-specialist

To determine an FDA submission pathway, define your device and intended use, then use a structured decision framework to evaluate eligibility for 510(k), De Novo, or PMA. This evaluates device risk and predicate availability to recommend the correct route.

510(k) requires proving substantial equivalence to a predicate, De Novo classifies novel low-to-moderate risk devices, and PMA requires rigorous clinical data for high-risk devices. Decision matrices compare these pathways based on risk level and predicate availability.

Prepare QSR and HIPAA compliance documentation by utilizing structured checklists and templates that align with FDA guidance. These tools help structure risk management and cybersecurity readiness assessments for medical device submissions.

Cybersecurity readiness is evaluated as part of FDA regulatory guidance for medical devices. Structured templates and checklists help assess cybersecurity risks and integrate the necessary controls into your submission documentation.

Choose a De Novo pathway when your medical device is low-to-moderate risk but lacks a valid predicate for a 510(k). Decision frameworks evaluate your device specifics to determine if De Novo classification is the appropriate route.

FDA submission templates and checklists are provided for QSR compliance, HIPAA risk management, and pathway selection. These structured documents align with official FDA guidance to streamline assembling your medical device submission plan.